213 related articles for article (PubMed ID: 1522596)
1. Active site of trypanothione reductase. A target for rational drug design.
Hunter WN; Bailey S; Habash J; Harrop SJ; Helliwell JR; Aboagye-Kwarteng T; Smith K; Fairlamb AH
J Mol Biol; 1992 Sep; 227(1):322-33. PubMed ID: 1522596
[TBL] [Abstract][Full Text] [Related]
2. Substrate interactions between trypanothione reductase and N1-glutathionylspermidine disulphide at 0.28-nm resolution.
Bailey S; Smith K; Fairlamb AH; Hunter WN
Eur J Biochem; 1993 Apr; 213(1):67-75. PubMed ID: 8477734
[TBL] [Abstract][Full Text] [Related]
3. Redox enzyme engineering: conversion of human glutathione reductase into a trypanothione reductase.
Bradley M; Bücheler US; Walsh CT
Biochemistry; 1991 Jun; 30(25):6124-7. PubMed ID: 2059620
[TBL] [Abstract][Full Text] [Related]
4. Molecular studies on trypanothione reductase: an antiparasitic target enzyme.
Walsh C; Bradley M; Nadeau K
Curr Top Cell Regul; 1992; 33():409-17. PubMed ID: 1354149
[No Abstract] [Full Text] [Related]
5. Engineering the substrate specificity of glutathione reductase toward that of trypanothione reduction.
Henderson GB; Murgolo NJ; Kuriyan J; Osapay K; Kominos D; Berry A; Scrutton NS; Hinchliffe NW; Perham RN; Cerami A
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8769-73. PubMed ID: 1924337
[TBL] [Abstract][Full Text] [Related]
6. X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4-A resolution.
Kuriyan J; Kong XP; Krishna TS; Sweet RM; Murgolo NJ; Field H; Cerami A; Henderson GB
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8764-8. PubMed ID: 1924336
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
[TBL] [Abstract][Full Text] [Related]
8. Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity.
Stoll VS; Simpson SJ; Krauth-Siegel RL; Walsh CT; Pai EF
Biochemistry; 1997 May; 36(21):6437-47. PubMed ID: 9174360
[TBL] [Abstract][Full Text] [Related]
9. The glutamyl binding site of trypanothione reductase from Crithidia fasciculata: enzyme kinetic properties of gamma-glutamyl-modified substrate analogues.
el-Waer AF; Smith K; McKie JH; Benson T; Fairlamb AH; Douglas KT
Biochim Biophys Acta; 1993 Nov; 1203(1):93-8. PubMed ID: 8105896
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the trypanothione reductase gene from Crithidia fasciculata and Trypanosoma brucei: comparison with other flavoprotein disulphide oxidoreductases with respect to substrate specificity and catalytic mechanism.
Aboagye-Kwarteng T; Smith K; Fairlamb AH
Mol Microbiol; 1992 Nov; 6(21):3089-99. PubMed ID: 1453951
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of parasite trypanothione reductase: acquisition of glutathione reductase activity in a triple mutant.
Sullivan FX; Sobolov SB; Bradley M; Walsh CT
Biochemistry; 1991 Mar; 30(11):2761-7. PubMed ID: 2007114
[TBL] [Abstract][Full Text] [Related]
12. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids.
Fairlamb AH; Blackburn P; Ulrich P; Chait BT; Cerami A
Science; 1985 Mar; 227(4693):1485-7. PubMed ID: 3883489
[TBL] [Abstract][Full Text] [Related]
13. The parasite-specific trypanothione metabolism of trypanosoma and leishmania.
Krauth-Siegel RL; Meiering SK; Schmidt H
Biol Chem; 2003 Apr; 384(4):539-49. PubMed ID: 12751784
[TBL] [Abstract][Full Text] [Related]
14. Preparative enzymatic synthesis of trypanothione and trypanothione analogues.
Comini MA; Dirdjaja N; Kaschel M; Krauth-Siegel RL
Int J Parasitol; 2009 Aug; 39(10):1059-62. PubMed ID: 19477177
[TBL] [Abstract][Full Text] [Related]
15. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
16. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures.
Benson TJ; McKie JH; Garforth J; Borges A; Fairlamb AH; Douglas KT
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):9-11. PubMed ID: 1355650
[TBL] [Abstract][Full Text] [Related]
17. Cloning, expression and reconstitution of the trypanothione-dependent peroxidase system of Crithidia fasciculata.
Tetaud E; Fairlamb AH
Mol Biochem Parasitol; 1998 Oct; 96(1-2):111-23. PubMed ID: 9851611
[TBL] [Abstract][Full Text] [Related]
18. Structure of trypanothione reductase from Crithidia fasciculata at 2.6 A resolution; enzyme-NADP interactions at 2.8 A resolution.
Bailey S; Fairlamb AH; Hunter WN
Acta Crystallogr D Biol Crystallogr; 1994 Mar; 50(Pt 2):139-54. PubMed ID: 15299452
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals.
Cunningham ML; Zvelebil MJ; Fairlamb AH
Eur J Biochem; 1994 Apr; 221(1):285-95. PubMed ID: 8168518
[TBL] [Abstract][Full Text] [Related]
20. The structure of Trypanosoma cruzi trypanothione reductase in the oxidized and NADPH reduced state.
Lantwin CB; Schlichting I; Kabsch W; Pai EF; Krauth-Siegel RL
Proteins; 1994 Feb; 18(2):161-73. PubMed ID: 8159665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
